Can hearing aids really slow down Alzheimer’s disease?

00

A systematic review of  literature on diabetes, its potential impacts on hearing loss, and a discussion of the clinical implications. By Emily Urry, PhD and Elizabeth Stewart, AuD, PhD Across a lifespan, an individual’s hearing capacity is influenced by genetic, biological, psychosocial, and environmental factors. These factors can either lead to hearing loss or protect…

Read More

Arterial hypertension – a leading cause of death

00

Arterial hypertension – a leading cause of death. Partly due to ageing, the rising incidence of obesity, and socio economic and environmental changes, its incidence increases worldwide. Hypertension commonly coexists with Type 2 diabetes, obesity, dyslipidaemia, sedentary lifestyle, and smoking leading to risk amplification. Blood pressure lowering by lifestyle modifications and anti hypertensive drugs reduce…

Read More

Wie erstellt man eine Text-zu-Sprache-Datei?

00

Wie erstellt man eine Text-zu-Sprache-Datei? Installiere das Text-zu-Sprache-Programm:  Beginne damit, ein Text-zu-Sprache-Programm auf deinem Computer oder mobilen Gerät herunterzuladen und zu installieren. Es gibt verschiedene Optionen wie Balabolka, NaturalReader oder TTSReader. Wir verwenden Balabolka. Beachte, dass Balabolka nur für Windows verfügbar ist.  Richte das Programm ein:  Nach dem Starten musst du möglicherweise einige anfängliche Einstellungen…

Read More

How to create text to speech files!

00

How to create a text to speech file Install the text-to-speech program:  Begin by downloading and installing a text-to-speech program on your computer or mobile device. There are various options available, such as Balabolka, NaturalReader, or TTSReader.  We currently use Balabolka which is only available for Windows Setting up this program: Upon launching, you might…

Read More

EU Commission’s revised pharma legislation.

00

European Institute of Women’s Health Press release:   For Immediate release The European Institute of Women’s Health (EIWH) welcomes the European Commission’s revised pharmaceutical legislation. The EIWH promotes women’s health in policy and research, and it is of utmost importance that women’s needs are reflected in this important piece of legislation. This revision comes at a…

Read More

Joint Press release between EPA and EIWH on MOU

00

PRESS RELEASE MOU signed between European Institute of Women’s Health (EIWH) and European Psychiatric Association (EPA) The EIWH and the EPA will work together on issues concerning gender and mental health IRELAND and FRANCE, February, 2023 – In November 2022, a Memorandum of Understanding (MOU) was signed between the European Institute of Women’s Health (EIWH)…

Read More

PRAC Ctte: 24 – 27/10/22

00

Pharmacovigilance Risk Assessment Ctte. Oct 22 EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders EMA safety committee (PRAC) recommended measures to minimise risks of serious side effects associated with Janus kinase (JAK) inhibitors used to treat various chronic inflammatory disorders. Side effects include cardiovascular conditions,…

Read More

Bulgaria: improved protection from violence

00

Bulgaria: Improved protection from violence against women and domestic violence. https://bit.ly/3NqAIHv | Lire en français Strasbourg, 20 May 2022 – In a letter addressed to the Prime Minister and the Minister of Justice of Bulgaria published today, Council of Europe Commissioner for Human Rights, Dunja Mijatović called on the Bulgarian authorities to improve the legal…

Read More